(Q38452866)

3 September 2017

title

Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis (English)

1 reference

3 September 2017

H Brenner

4

0 references

author name string

A Gondos

1

1 reference

3 September 2017

F Bray

2

1 reference

3 September 2017

T Hakulinen

3

1 reference

3 September 2017

EUNICE Survival Working Group

5

1 reference

3 September 2017

publication date

9 December 2008

1 reference

3 September 2017

1 reference

3 September 2017

volume

20

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

564-573

1 reference

Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Cancer survival increases in Europe, but international differences remain wide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Interpreting trends in cancer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Are increasing 5-year survival rates evidence of success against cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Evidence of prostate cancer screening in a UK region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Adjuvant therapy in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Impact of a surgical training programme on rectal cancer outcomes in Stockholm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Training and quality assurance for rectal cancer: 20 years of data is enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Quantifying the role of PSA screening in the US prostate cancer mortality decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Chronic myeloid leukemia: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Progress and prospects on melanoma: the way forward for early detection and reduced mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Up-to-Date Estimates of Cancer Patient Survival Even with Common Latency in Cancer Registration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Up-to-Date Long-Term Survival Curves of Patients With Cancer by Period Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Model based hybrid analysis of cancer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN639

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN639

1 reference

3 September 2017

1 reference